Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121901043 | 12190104 | 3 | F | 20160311 | 20160829 | 20160318 | 20160901 | PER | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-020332 | BRISTOL MYERS SQUIBB | 93.48 | YR | M | Y | 60.40000 | KG | 20160901 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121901043 | 12190104 | 1 | PS | ELIQUIS | APIXABAN | 1 | Oral | 5 MG, BID | 202155 | 5 | MG | FILM-COATED TABLET | BID | ||||||
| 121901043 | 12190104 | 2 | SS | WARFARIN SODIUM. | WARFARIN SODIUM | 1 | Oral | 26 MG, QWK | N | 0 | 26 | MG | TABLET | /wk | |||||
| 121901043 | 12190104 | 3 | C | FLOMAX | TAMSULOSIN HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 121901043 | 12190104 | 4 | C | PROSCAR | FINASTERIDE | 1 | Oral | 5 MG, QD | U | 0 | 5 | MG | QD | ||||||
| 121901043 | 12190104 | 5 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | UNK | U | 0 | |||||||||
| 121901043 | 12190104 | 6 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 121901043 | 12190104 | 7 | C | DETROL | TOLTERODINE TARTRATE | 1 | Oral | 2 MG, QD | U | 0 | 2 | MG | QD | ||||||
| 121901043 | 12190104 | 8 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 5 MG, QD | U | 0 | 5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121901043 | 12190104 | 1 | Cerebrovascular accident prophylaxis |
| 121901043 | 12190104 | 2 | Atrial fibrillation |
| 121901043 | 12190104 | 3 | Adverse event |
| 121901043 | 12190104 | 4 | Adverse event |
| 121901043 | 12190104 | 5 | Gout |
| 121901043 | 12190104 | 6 | Hiatus hernia |
| 121901043 | 12190104 | 7 | Urinary incontinence |
| 121901043 | 12190104 | 8 | Polyuria |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121901043 | 12190104 | Contraindicated product administered | |
| 121901043 | 12190104 | Rash macular |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121901043 | 12190104 | 1 | 20160308 | 0 | ||
| 121901043 | 12190104 | 8 | 2015 | 0 |